eavesdropping in houston

Overheard: Energy transition experts weigh in at Houston climatetech conference

Greentown Labs hosted its Climatetech Summit from both its Houston location and its Boston-area office. Photo via greentownlabs.com

This week, world leaders are discussing climate change and the future of our planet at the United Nations Climate Change Conference, also known as COP26, but local leaders were also discussing much closer to home.

Greentown Labs hosted its Climatetech Summit on Thursday, November 4, at both its offices in Houston and Sommerville, Massachusetts. The hybrid event featured a full day of networking, panels, and thought leadership.

Missed the conversation? Here are five key moments from the event.

​"Houston cannot transition without transitioning its workforce, and we need to help with that and make sure that people understand that. Demystifying the jobs of the future is key."

— says Juliana Garaizar, Greentown Labs' head of Houston incubator and vice president of innovation, in her welcome address.

"The energy transition in Houston needs to happen in an equitable way," she says. "Houston is the most diverse city in the US. It is up to us now to make it the most inclusive."

"The world will continue to need a lot of hydrocarbons for quite a long period of time, and Houston can and should remain a leader there. But it will not be an engine for growth."

— says Bobby Tudor, former chair of the Greater Houston Partnership and chairman of Tudor, Pickering, Holt & Co, in his keynote.

"If we are not going to have that business, which accounts for approximately 40 percent of all jobs in Greater Houston, be an engine of growth, we sure as heck better find businesses that are, or we will not have the same kind of prosperity that we've had in our region," Tudor says.

"The Energy Capital of the World will be the leader in the global energy transition."

— says Mayor Sylvester Turner in his address.

"As a lifelong Houston, I am proud of our history and proud of the innovation, growth, and prosperity the energy industry brings to our community," he continues. "But, as leaders of the energy industry, I believe it is our responsibility to continue this legacy and develop the innovative technologies and practices needed to decarbonize the entire energy sector worldwide."

"Texas has more potential to produce clean energy — wind, solar, storage — and efficiency than any other state."

says HARC President + CEO John Hall in his address.

"And we're fortunate that today — even though we continue to lead the country in producing oil and gas — 40 percent of the electricity being used in this state is zero emitting."

"You don't get change by wishing and hoping. You need to plan and to act."

says Quantum New Energy CEO Patricia Vega on the panel about transitioning the workforce.

"We live in a world where we can track steps, calories, and likes on social media, but if I ask each one of you what is your carbon footprint or carbon efficiency, many of us don't know how to answer those questions and don't have the tools," she adds.

Trending News

Building Houston

 
 

Optellum, which has its United States operations based in the TMC Innovation Institute, has raised fresh funding. Photo via Getty Images

A Oxford-based health tech startup that has its United States headquarters in Houston has announced the close of its series A round of funding.

Optellum, which has created a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a series A funding round. The round was led by United Kingdom-based Mercia, with additional investors California-based Intuitive Ventures and New York-based Black Opal Ventures. Existing investors, including St John's College in the University of Oxford, IQ Capital, and the family office of Sir Martin & Lady Audrey Wood, also participated in the round, per a news release.

"Lung cancer is an urgent public health crisis and Optellum's groundbreaking approach utilizing AI to accelerate early detection and intervention may fundamentally alter the healthcare community's approach to combating this disease," says Dr. Oliver Keown, managing director of Intuitive Ventures, in the release. "Optellum is uniquely positioned to align and provide considerable value to patients, providers, and payers alike. Intuitive Ventures is thrilled to provide our full arsenal of financial and strategic support to Optellum as we work towards a world of better outcomes for cancer patients."

The fresh funding will go toward scaling Optellum's operations and commercial launches in the United Kingdom and in the United States. Additionally, the company plans to expand its platform, including providing personalized therapy support using imaging data with molecular data, robotics, and liquid biopsies.

"With this strong support and commitment of highly specialized investors, we are positioned to accelerate commercial deployment in both the UK and the United States to expand our installed base," says Jason Pesterfield, CEO at Optellum, in the release. "Following years of research and clinical trials that have shown the impact of our software on the diagnosis of at-risk lung nodules, we're focused on expanding patient access to this crucial technology and identifying deadly lung cancer faster in more at-risk people. The funding will also boost our research and development with world-leading institutions and partners to progress further innovation."

Optellum's software provides support for physicians making decisions in early lung cancer diagnosis and treatment. The company was launched to provide better diagnostics and early-stage treatment to increase survival rates and improve health outcomes.

Last year, Optellum — whose U.S. headquarters is at Houston's TMC Innovation Institute — announced it would be included in J&J's Lung Cancer Initiative. The startup was a 2019 graduate of the Texas Medical Center's accelerator and its software platform, Virtual Nodule Clinic, received FDA clearance, CE-MDR in the EU, and UKCA in the UK.

"Optellum is the latest in a series of companies to channel research from the UK's world-leading universities into commercially viable products that can make a difference to the provision of medical care," says Mercia Investment Director Stephen Johnson in the release. "Having observed Optellum achieve great milestones over the years, we are now excited to become part of their success and apply our experience with scaling up software and deep-tech companies to help accelerate Optellum's impact on patient lives across the world."

Trending News